{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:35:47Z","timestamp":1722472547836},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.7759\/cureus.65828","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T11:00:41Z","timestamp":1722423641000},"source":"Crossref","is-referenced-by-count":0,"title":["Muir-Torre Syndrome: A Case Report and a Literature Review of Genetic Insights and Cancer Surveillance"],"prefix":"10.7759","author":[{"given":"Shubam","family":"Trehan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjot","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanishka","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FNU","family":"Kalpana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Antil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.98.5.549","article-title":"Multiple sebaceous tumors","volume":"98","author":"Torre D","year":"1968","unstructured":"Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968, 98:549-51. 10.1001\/archderm.98.5.549","journal-title":"Arch Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2002.290705.x","article-title":"Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome","volume":"29","author":"Machin P","year":"2002","unstructured":"Machin P, Catasus L, Pons C, et al.. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002, 29:415-20. 10.1034\/j.1600-0560.2002.290705.x","journal-title":"J Cutan Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70465-4","article-title":"Muir-Torre syndrome","volume":"6","author":"Ponti G","year":"2005","unstructured":"Ponti G, de Leon MP. Muir-Torre syndrome. Lancet Oncol. 2005, 6:980. 10.1016\/S1470-2045(05)70465-4","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0693","article-title":"Prevalence and penetrance of major genes and polygenes for colorectal cancer","volume":"26","author":"Win AK","year":"2017","unstructured":"Win AK, Jenkins MA, Dowty JG, et al.. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2017, 26:404-12. 10.1158\/1055-9965.EPI-16-0693","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2009.01248.x","article-title":"Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm","volume":"36","author":"Abbas O","year":"2009","unstructured":"Abbas O, Mahalingam M. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol. 2009, 36:613-19. 10.1111\/j.1600-0560.2009.01248.x","journal-title":"J Cutan Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona V","year":"2011","unstructured":"Bonadona V, Bona\u00efti B, Olschwang S, et al.. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011, 305:2304-10. 10.1001\/jama.2011.743","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.19","article-title":"A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome","volume":"16","author":"Roberts ME","year":"2014","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC, et al.. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med. 2014, 16:711-16. 10.1038\/gim.2014.19","journal-title":"Genet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-017-0346-7","article-title":"Usefulness of PET\/CT for early detection of internal malignancies in patients with Muir-Torre syndrome: report of two cases","volume":"3","author":"Ishiguro Y","year":"2017","unstructured":"Ishiguro Y, Homma S, Yoshida T, et al.. Usefulness of PET\/CT for early detection of internal malignancies in patients with Muir-Torre syndrome: report of two cases. Surg Case Rep. 2017, 3:71. 10.1186\/s40792-017-0346-7","journal-title":"Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.074","article-title":"Muir-Torre syndrome (MTS): an update and approach to diagnosis and management","volume":"74","author":"John AM","year":"2016","unstructured":"John AM, Schwartz RA. Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016, 74:558-66. 10.1016\/j.jaad.2015.09.074","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000572","article-title":"Muir-Torre syndrome with a frame-shift mutation in the MSH2 gene: a rare case report and literature review","volume":"39","author":"Chen Q","year":"2020","unstructured":"Chen Q, Wang M, Xu Z, Wang M, Jin S, Tian S, Xiao S. Muir-Torre syndrome with a frame-shift mutation in the MSH2 gene: a rare case report and literature review. Int J Gynecol Pathol. 2020, 39:136-40. 10.1097\/PGP.0000000000000572","journal-title":"Int J Gynecol Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/1516-3180.2014.1321634","article-title":"Muir-Torre syndrome: case report and molecular characterization","volume":"132","author":"Rios CA","year":"2014","unstructured":"Rios CA, Villal\u00f3n R, Mu\u00f1oz J, Acu\u00f1a M, Cifuentes L. Muir-Torre syndrome: case report and molecular characterization. Sao Paulo Med J. 2014, 132:61-4. 10.1590\/1516-3180.2014.1321634","journal-title":"Sao Paulo Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.110512","article-title":"Simultaneous Muir-Torre and Turcot's syndrome: a case report and review of the literature","volume":"4","author":"Grandhi R","year":"2013","unstructured":"Grandhi R, Deibert CP, Pirris SM, Lembersky B, Mintz AH. Simultaneous Muir-Torre and Turcot's syndrome: a case report and review of the literature. Surg Neurol Int. 2013, 4:52. 10.4103\/2152-7806.110512","journal-title":"Surg Neurol Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1592-7","article-title":"Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report","volume":"20","author":"Tomonari M","year":"2019","unstructured":"Tomonari M, Shimada M, Nakada Y, et al.. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report. BMC Nephrol. 2019, 20:394. 10.1186\/s12882-019-1592-7","journal-title":"BMC Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman MJ","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, et al.. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017, 18:1182-91. 10.1016\/S1470-2045(17)30422-9","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.09.054","article-title":"Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome","volume":"68","author":"Ponti G","year":"2013","unstructured":"Ponti G, Longo C. Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome. J Am Acad Dermatol. 2013, 68:509-10. 10.1016\/j.jaad.2012.09.054","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33103","article-title":"Muir-Torre syndrome: abdominal sebaceous carcinoma","volume":"14","author":"Bui A","year":"2022","unstructured":"Bui A, Shah S, Winston N, Mahmoud A. Muir-Torre syndrome: abdominal sebaceous carcinoma. Cureus. 2022, 14:e33103. 10.7759\/cureus.33103","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01218-y","article-title":"Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence","volume":"15","author":"Zhang S","year":"2023","unstructured":"Zhang S, Yuan L, Danilova L, et al.. Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence. Genome Med. 2023, 15:72. 10.1186\/s13073-023-01218-y","journal-title":"Genome Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.12.008","article-title":"VISTA: a mediator of quiescence and a promising target in cancer immunotherapy","volume":"42","author":"Yuan L","year":"2021","unstructured":"Yuan L, Tatineni J, Mahoney KM, Freeman GJ. VISTA: a mediator of quiescence and a promising target in cancer immunotherapy. Trends Immunol. 2021, 42:209-27. 10.1016\/j.it.2020.12.008","journal-title":"Trends Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280151-muir-torre-syndrome-a-case-report-and-a-literature-review-of-genetic-insights-and-cancer-surveillance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T11:00:44Z","timestamp":1722423644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280151-muir-torre-syndrome-a-case-report-and-a-literature-review-of-genetic-insights-and-cancer-surveillance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.65828","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}